Description
This product utilizes CD4+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target CD229 ( clone 4H6M6). We employs the Lentivirus (SV40-GFP-IL-17-BamHI) vector components and the SynExpress system of the histone modification sites RNA Editing/Delayed feedback for a robust and sustained response against cancers.
Host
Human
Target
CD229
Clone
4H6M6
Species Reactivity
Human
Cell Source
Synthetic CD4+ T cells
Sensor Gene
GFP
Promoter
SV40
Effector Gene
IL-17
Insertion Sites
BamHI
Gene Modification
RNA Editing
Modification Domain
Histone modification sites
Carrier Type
Lentivirus
Transformation Accuracy
0.95
Cell Culture
Adherent Culture

For Research Use Only | Not For Clinical Use

Online Inquiry
Related Products
Copyright © 2025 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.